ATR and neoplasm: The selective inhibition of ATR is a significant attribute of its therapeutic potential in oncology, where ATR inhibitors enhance the efficacy of DNA-damaging agents by exploiting tumour cells’ heightened replication stress and compromised DNA repair mechanisms.